Open Access. Powered by Scholars. Published by Universities.®

Biomedical Engineering and Bioengineering Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 3 of 3

Full-Text Articles in Biomedical Engineering and Bioengineering

Patient-Derived Hydrogel As A Sacrificial Matrix For Efficient Cell Loading, Shalmli U. Joshi Apr 2017

Patient-Derived Hydrogel As A Sacrificial Matrix For Efficient Cell Loading, Shalmli U. Joshi

Honors Scholar Theses

The field of tissue engineering focuses on delivering patient-derived stem cells to the body through the use of degradable biomaterials, such as hydrogels, which are infused into engineered scaffolds. Hydrogels act as templates to support and guide cells towards the regeneration of new tissue. In this study, we introduce a completely intraoperative procedure for obtaining a fibrin hydrogel for tissue engineering applications. In the past, fibrin hydrogel has been commonly formed by combining fibrinogen protein with animal-derived thrombin. Instead, we have developed an automated, and therefore reproducible, protocol to isolate and form fibrin hydrogel without the use of animal-derived thrombin. …


The Agile Approach In Pharmaceutical Software Development, Priyal Bhargava Apr 2017

The Agile Approach In Pharmaceutical Software Development, Priyal Bhargava

Honors Scholar Theses

The Agile development model is increasingly being adopted by the pharmaceutical industry for software development. Currently, there are several software projects under development by pharmaceutical companies that are using the Agile process. Other methodologies such as the Waterfall process, a traditional approach to project management, have evolved over time and been compared against the Agile method. Also there are conflicts of interest which should be taken into consideration when in a pharmaceutical setting such as abiding by FDA regulations. In addition, Agile’s sub-divisional approaches add to the versatility of how this iterative approach is applied in the pharmaceutical industry. The …


Engineering A Fluorescent Protease Sensor For In Vivo Protein Detection, Thomas C. Kinard Jan 2017

Engineering A Fluorescent Protease Sensor For In Vivo Protein Detection, Thomas C. Kinard

Honors Scholar Theses

This report details the results of an ongoing project to engineer a mutant form of Red Fluorescent Protein (RFP) variant mCherry that acts as a real-time in vivo protease sensor. The sought-after mutant only becomes fluorescent when exposed to Tobacco Etch Virus (TEV) Protease, this system’s model protease. This will be accomplished via the insertion of the TEV Protease Recognition Site (TEV-PRS) in such a position that, before cleavage, will prevent the protein from folding to fluorescent conformation, but upon cleavage, will allow for fluorescent conformation to occur. The cylindrical structure of the protein, composed of beta-pleated sheets, contains “loops” …